Accuray to introduce Volo Ultra at ASTRO 2021
October 19, 2021 -- Radiation oncology firm Accuray plans to feature its Volo Ultra planning upgrade at the annual meeting of the American Society for Radiation Oncology (ASTRO), which is being held October 24-27. Read More
Varian's Embozene microspheres receive 'breakthrough' designation
October 14, 2021 -- Varian has received a breakthrough device designation from the U.S. Food and Drug Administration for its Embozene microspheres for genicular artery embolization for symptomatic knee osteoarthritis. Read More
ARTMS seeks nod from Health Canada for Ga-68 production
October 14, 2021 -- ARTMS has submitted a drug master file to the Health Products and Food Branch of Health Canada for the production of gallium-68 (Ga-68). Read More
Consider the esophagus when it comes to breast cancer radiotherapy
October 11, 2021 -- Routinely avoiding the esophagus during radiation therapy for breast cancer may decrease the risk of esophageal cancer years later, according to research from Ireland published October 7 in Radiotherapy and Oncology. Read More
Sirtex touts 1st administration of yttrium-90 microspheres in China
October 11, 2021 -- Radiation oncology firm Sirtex Medical is highlighting the successful first administration of its SIR-Spheres yttrium-90 resin microspheres in China. Read More
ASTRO highlights program at 2021 annual meeting
October 11, 2021 -- The American Society for Radiation Oncology (ASTRO) is highlighting research and clinical trial results it will feature at its annual meeting in Chicago from October 24 to 27. Read More
Alpha Tau gets FDA 'breakthrough' nod for brain tumor rad therapy
October 8, 2021 -- Alpha Tau Medical recently received a breakthrough device designation from the U.S. Food and Drug Administration (FDA) for its Alpha DaRT treatment. Read More
Nanobiotix highlights ASTRO research studies
October 7, 2021 -- Nanobiotix will present results from clinical trials of its NBTXR3 radioenhancer at the 2021 American Society for Radiation Oncology (ASTRO) meeting, which will be held October 24-27 in Chicago. Read More
ViewRay submits 510(k) for updated version of MRIdian
October 4, 2021 -- Image-guided radiation therapy vendor ViewRay has submitted a 510(k) application for an updated version of its MRIdian MRI-guided radiation therapy system. Read More
Accuray inks collaboration with C-RAD
October 4, 2021 -- Radiation therapy firm Accuray has signed a collaboration agreement with C-RAD to incorporate C-RAD's Catalyst+ HD software into Accuray's Radixact breast cancer radiation therapy treatment system. Read More
Special Feature
IMV: Imaging boosts precision in radiation therapy

Radiation therapy is a relatively stable market, with procedure volume growing at an average annual rate of 2%. But major technological changes in radiation oncology are brewing under the surface, according to a new report by IMV Medical Information Division. Read more